Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Weight loss in patients with type 2 diabetes (T2D) mellitus receiving once-weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: An AWARD-4 <em>post-hoc</em> analysis across baseline body mass index subgroups. Have a read: https://www.m3india.in/contents/journal/weight-loss-in-patients-with-type-2-diabetes-t2d?utm_campaign=unset&utm_medium=share&utm_source=ref_wa